Stunting affected at least 165 million children in the world in 2011 and was found in 7% of children in high-income countries and in 28% of children in low-to middle-income countries. 1 Although the causes of stunting are many, maternal nutrition is one of the causes that can be modified by interventions. 2 It is therefore of great interest that the maternal status of a micronutrient, vitamin B12, assessed when the infant is being breastfed, is related to the height of the child several years later. 3 In this study on women and children in Nepal, blood samples from mothers and infants were taken when the infants were on average 7 months old and were being breastfed. The plasma total vitamin B12 of both mother and infant were each associated with the height of the child aged 5 y. Furthermore, the vitamin B12 intake of the mother while breastfeeding was also related to the child's height at age 5 y. The mean maternal daily intake of B12 was 0.8 μg, well below the RDA of 2.6 μg but only 5% of mothers were B12 deficient by the usual definition (<148 pmol/L in plasma). It is striking that the maternal B12 status over the whole range of observed plasma values was linearly related to the child's height at age 5 y. Likewise, the association between B12 intake and height was approximately linear over the whole range of intake. Each increment in maternal B12 intake of 1 μg was associated with an increase in the child's height of 1.7 cm. The authors stated that their results "do not suggest any cutoffs indicating when intake or status was adequate and indicate that most of the participants would benefit from increasing their intake of vitamin B12". 3 It has been pointed out previously that in general several adverse outcomes are related to B12 status in the low-normal range but above the traditional cutoff value for deficiency. 4,5 Does this mean that we should ensure that maternal B12 status is well above 148 pmol/L in mothers? The vitamin B12 status in pregnant woman worldwide is poor: a survey of 11 cohorts including 11,381 women showed a deficiency (<148 pmol/L) rate of 27.5% and an insufficiency (<300 pmol/L) rate of 60%. 5 A large systematic review including 57 cohorts of >30,000 pregnant women found deficiency rates of 21%, 19%, and 29% in the first, second, and third trimesters, respectively. 6 There is evidence that poor B12 status is harmful for the health of the pregnant woman. For example, it increases the risk of gestational diabetes, obesity, and anemia not only in low-and middle-income countries and in countries with a high proportion of vegetarians, but also in high-income countries. 7 Low pregnancy B12 status across the whole normal range increases the risk of preterm birth. 8 Furthermore, B12 interacts with other nutrients. In pregnant women with low B12 status and high folate status there is an increased risk of gestational diabetes, 9 of small for gestational age babies 10 and of insulin resistance and obesity in the children aged 6 y. 11